Dublin, June 10, 2025 (GLOBE NEWSWIRE) — The “Oncology Diagnostics: Global Markets” report has been added to ResearchAndMarkets.com’s providing.
The worldwide marketplace for oncology diagnostics is estimated to extend from $77.6 billion in 2024 to achieve $101.5 billion by 2029, at a compound annual progress fee (CAGR) of 5.5% from 2024 by means of 2029.
The bottom yr for the examine is 2023, 2024 is the estimated yr, with projections by means of 2029, together with compound annual progress charges (CAGRs) for the forecast interval.
This report analyzes the oncology diagnostics market and the aggressive panorama. The profiles of a number of main corporations, together with their revenues, product portfolios and up to date actions are additionally examined. The report analyzes market dynamics, together with drivers, limitations, challenges and alternatives, and discusses present and potential market measurement. The report will allow corporations within the trade to make knowledgeable selections concerning the manufacturing and licensing of products and providers.
The oncology diagnostics market is rising at a gentle fee pushed by the growing incidence and the prevalence of a variety of cancers globally, R&D and new product launches by the key gamers out there, strategic initiatives by the key gamers, and growing numbers of personal diagnostic facilities in rising markets.
Key Attributes:
| Report Attribute | Particulars |
| No. of Pages | 192 |
| Forecast Interval | 2024 – 2029 |
| Estimated Market Worth (USD) in 2024 | $77.6 Billion |
| Forecasted Market Worth (USD) by 2029 | $101.5 Billion |
| Compound Annual Development Charge | 5.5% |
| Areas Lined | World |
The report contains:
- 94 information tables and 59 further tables
- Analyses of worldwide market developments for oncology diagnostics, with market income information from 2021 to 2024, forecasts and projected CAGRs by means of 2029
- Estimates of the scale and progress of the worldwide market, and a corresponding market share evaluation by product sort, utility, finish consumer, and area
- Information and figures pertaining to the key market dynamics, alternatives and challenges, rising applied sciences, laws, and impacts of macroeconomic variables
- Insights derived from the Porter’s 5 Forces mannequin, in addition to world provide chain and PESTLE analyses
- Protection of remedies in improvement for late- and early-stage oncolytic viruses, together with epidemiological info, information equivalent to most cancers incidence and mortality developments
- Analysis of latest patent exercise that includes key granted and printed patents
- Insights into oncology therapeutics analysis exercise, rising applied sciences, scientific trials and pipeline merchandise
- Overview of sustainability developments and ESG developments, with emphasis on shopper attitudes, and the ESG scores and practices of main corporations
- Evaluation of the trade construction, together with corporations’ market shares and rankings, strategic alliances, M&A exercise and a enterprise funding outlook
- Firm profiles of main gamers inside the trade, together with F. Hoffmann-La Roche Ltd., Danaher Corp., Agilent Applied sciences Inc., Siemens Healthineers AG, and GE HealthCare
Key Subjects Lined:
Chapter 1 Government Abstract
- Market Outlook
- Scope of Report
- Market Abstract
- Market Dynamics and Development Elements
- Rising Applied sciences
- Segmental Evaluation
- Regional Evaluation
- Strategic Initiatives
- Conclusion
Chapter 2 Market Overview
- Overview
- Macroeconomic Elements Evaluation
- Impression of the U.S.-China Commerce Struggle
- Porter’s 5 Forces Evaluation within the Oncology Market
Chapter 3 Market Dynamics
- Key Takeaways
- Market Drivers
- Rising Incidence of Most cancers Instances
- Demand for Earlier Intervention and Preventive Diagnostic Screening
- Rising Adoption of Companion Diagnostics
- Growing Ageing Inhabitants Worldwide
- Market Alternatives
- Increasing Most cancers Screening
- Enhancing Entry to Superior Applied sciences
- Market Restraints
- Complicated Reimbursement Insurance policies
- Lack of Most cancers Consciousness
- Value of Oncology Diagnostic Exams
- Turnaround Time of Oncology Diagnostics
- Market Challenges
- Lack of Expert Professionals
- Complicated Pattern Preparation and Dealing with
Chapter 4 Regulatory Panorama
- Market Laws, by Prime Nation/Area
- The U.S.
- Europe
- Japan
- China
Chapter 5 Rising Applied sciences and Developments
- Rising Applied sciences
- AI in Oncology Diagnostics
- Multi-Most cancers Early Detection (MCED)
- Theranostics
- Digital Pathology and AI Integration
- Patent Evaluation
- Key Takeaways
Chapter 6 Oncology Diagnostics Market
- Section Breakdown
- World Market Insights
- Market Breakdown by Product Sort
- Diagnostics Imaging
- Endoscopy Units
- Tumor Biomarker Exams
- Biopsy Units
- Hematoxylin and Eosin
- Immunohistochemistry
- In situ Hybridization
- Polymerase Chain Response
- Subsequent-Technology Sequencing
- Others
- Market Breakdown by Utility
- Breast Most cancers
- Lung Most cancers
- Colorectal Most cancers
- Prostate Most cancers
- Gastric Most cancers
- Different Purposes
- Market Breakdown by Finish Consumer
- Hospitals, Most cancers Facilities and Clinics
- Diagnostic Imaging and Reference Laboratories
- Others
- Geographic Breakdown
- Market Breakdown, by Area
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- South America
- Center East and Africa (MEA)
Chapter 7 Aggressive Intelligence
- Firm Share Evaluation
- Strategic Initiatives
Chapter 8 Sustainability within the Marketplace for Oncology Diagnostics: An ESG Perspective
- Introduction to ESG
- ESG Efficiency Evaluation
- Environmental Efficiency
- Social Efficiency
- Governance Efficiency
- Concluding Remarks
Chapter 9 Appendix
- Analysis Methodology
- References
- Abbreviations
- Firm Profiles
- ABBOTT
- AGILENT TECHNOLOGIES INC.
- BD
- BIOMERIEUX
- BIO-RAD LABORATORIES INC.
- DANAHER CORP.
- F. HOFFMANN-LA ROCHE LTD.
- GE HEALTHCARE
- ILLUMINA INC.
- KONINKLIJKE PHILIPS N.V.
- MERCK KGAA
- MYRIAD GENETICS INC.
- QIAGEN
- SIEMENS HEALTHINEERS AG
- THERMO FISHER SCIENTIFIC INC.
- ZYTOVISION GMBH
- Different Rising Gamers within the Oncology Diagnostics Market
Record of Tables
Abstract Desk: World Marketplace for Oncology Diagnostics, by Product Sort, By way of 2029
Desk 1: World Incidence of All Most cancers Instances, by WHO Area, 2022-2045
Desk 2: World Incidence of Most cancers Instances, Each Sexes, by Most cancers Sort, 2022
Desk 3: Most cancers Remedies Primarily based on Particular Exams
Desk 4: Choose FDA-Permitted AI-Related/Associable-Outfitted Medical Units
Desk 5: Chosen Patent Grants in Oncology Diagnostics, 2023-2025
Desk 6: World Oncology Diagnostics Market, by Product Sort, By way of 2029
Desk 7: World Diagnostics Imaging Market, by Area, By way of 2029
Desk 8: World Endoscopy Market, by Area, By way of 2029
Desk 9: World Tumor Biomarker Exams Market, by Area, By way of 2029
Desk 10: World Biopsy Units Market, by Area, By way of 2029
Desk 11: World H&E and Particular Stains Diagnostics Market, by Area, By way of 2029
Desk 12: World IHC Oncology Diagnostics Market, by Area, By way of 2029
Desk 13: World ISH Oncology Diagnostics Market, by Area, By way of 2029
Desk 14: World PCR Oncology Diagnostics Market, by Area, By way of 2029
Desk 15: World NGS Oncology Diagnostics Market, by Area, By way of 2029
Desk 16: World Different Oncology Diagnostics Exams Market, by Area, By way of 2029
Desk 17: World Oncology Diagnostics Market, by Utility, By way of 2029
Desk 18: World Breast Most cancers Diagnostics Market, by Area, By way of 2029
Desk 19: World Lung Most cancers Diagnostics Market, by Area, By way of 2029
Desk 20: World Colorectal Most cancers Diagnostics Market, by Area, By way of 2029
Desk 21: World Prostate Most cancers Diagnostics Market, by Area, By way of 2029
Desk 22: World Gastric Most cancers Diagnostics Market, by Area, By way of 2029
Desk 23: World Oncology Diagnostics Market in Different Most cancers Purposes, by Area, By way of 2029
Desk 24: World Oncology Diagnostics Market, by Finish Consumer, By way of 2029
Desk 25: World Oncology Diagnostics Market in Hospitals, Most cancers Facilities and Clinics, By way of 2029
Desk 26: World Oncology Diagnostics Market in Diagnostic Imaging and Reference Laboratories, By way of 2029
Desk 27: World Oncology Diagnostics Market in Different Finish Makes use of, By way of 2029
Desk 28: World Oncology Diagnostics Market, by Area, By way of 2029
Desk 29: North American Oncology Diagnostics Market, by Nation, By way of 2029
Desk 30: U.S. Oncology Diagnostics Market, by Product Sort, By way of 2029
Desk 31: U.S. Oncology Diagnostics Market, by Utility, By way of 2029
Desk 32: U.S. Oncology Diagnostics Market, by Finish Consumer, By way of 2029
Desk 33: Canadian Oncology Diagnostics Market, by Product Sort, By way of 2029
Desk 34: Canadian Oncology Diagnostics Market, by Utility, By way of 2029
Desk 35: Canadian Oncology Diagnostics Market, by Finish Consumer, By way of 2029
Desk 36: Mexican Oncology Diagnostics Market, by Product Sort, By way of 2029
Desk 37: Mexican Oncology Diagnostics Market, by Utility, By way of 2029
Desk 38: Mexican Oncology Diagnostics Market, by Finish Consumer, By way of 2029
Desk 39: European Oncology Diagnostics Market, by Nation, By way of 2029
Desk 40: Most cancers Incidence and Mortality Numbers in Germany, Each Sexes, 2022
Desk 41: German Oncology Diagnostics Market, by Product Sort, By way of 2029
Desk 42: German Oncology Diagnostics Market, by Utility, By way of 2029
Desk 43: German Oncology Diagnostics Market, by Finish Consumer, By way of 2029
Desk 44: Most cancers Incidence and Mortality Numbers in France, Each Sexes, 2022
Desk 45: French Oncology Diagnostics Market, by Product Sort, By way of 2029
Desk 46: French Oncology Diagnostics Market, by Utility, By way of 2029
Desk 47: French Oncology Diagnostics Market, by Finish Consumer, By way of 2029
Desk 48: New Instances of Most cancers Identified Every Yr within the U.Okay., 2021
Desk 49: The U.Okay. Oncology Diagnostics Market, by Product Sort, By way of 2029
Desk 50: The U.Okay. Oncology Diagnostics Market, by Utility, By way of 2029
Desk 51: The U.Okay. Oncology Diagnostics Market, by Finish Consumer, By way of 2029
Desk 52: Most cancers Incidence and Mortality Numbers in Italy, Each Sexes, 2022
Desk 53: Italian Oncology Diagnostics Market, by Product Sort, By way of 2029
Desk 54: Italian Oncology Diagnostics Market, by Utility, By way of 2029
Desk 55: Italian Oncology Diagnostics Market, by Finish Consumer, By way of 2029
Desk 56: Most cancers Incidence and Mortality Numbers in Spain, Each Sexes, 2022
Desk 57: Spanish Oncology Diagnostics Market, by Product Sort, By way of 2029
Desk 58: Spanish Oncology Diagnostics Market, by Utility, By way of 2029
Desk 59: Spanish Oncology Diagnostics Market, by Finish Consumer, By way of 2029
Desk 60: Remainder of European International locations’ Oncology Diagnostics Market, by Product Sort, By way of 2029
Desk 61: Remainder of European International locations’ Oncology Diagnostics Market, by Utility, By way of 2029
Desk 62: Remainder of European International locations’ Oncology Diagnostics Market, by Finish Consumer, By way of 2029
Desk 63: Asia-Pacific Oncology Diagnostics Market, by Nation, By way of 2029
Desk 64: Most cancers Incidence and Mortality Numbers in China, Each Sexes, 2022
Desk 65: Chinese language Oncology Diagnostics Market, by Product Sort, By way of 2029
Desk 66: Chinese language Oncology Diagnostics Market, by Utility, By way of 2029
Desk 67: Chinese language Oncology Diagnostics Market, by Finish Consumer, By way of 2029
Desk 68: Most cancers Incidence and Mortality Numbers in Japan, Each Sexes, 2022
Desk 69: Japanese Oncology Diagnostics Market, by Product Sort, By way of 2029
Desk 70: Japanese Oncology Diagnostics Market, by Utility, By way of 2029
Desk 71: Japanese Oncology Diagnostics Market, by Finish Consumer, By way of 2029
Desk 72: Most cancers Incidence and Mortality Numbers in India, Each Sexes, 2022
Desk 73: Indian Oncology Diagnostics Market, by Product Sort, By way of 2029
Desk 74: Indian Oncology Diagnostics Market, by Utility, By way of 2029
Desk 75: Indian Oncology Diagnostics Market, by Finish Consumer, By way of 2029
Desk 76: Remainder of Asia-Pacific Oncology Diagnostics Market, by Product Sort, By way of 2029
Desk 77: Remainder of Asia-Pacific Oncology Diagnostics Market, by Utility, By way of 2029
Desk 78: Remainder of Asia-Pacific Oncology Diagnostics Market, by Finish Consumer, By way of 2029
Desk 79: South American Oncology Diagnostics Market, by Nation, By way of 2029
Desk 80: Brazilian Oncology Diagnostics Market, by Product Sort, By way of 2029
Desk 81: Brazilian Oncology Diagnostics Market, by Utility, By way of 2029
Desk 82: Brazilian Oncology Diagnostics Market, by Finish Consumer, By way of 2029
Desk 83: Argentine Oncology Diagnostics Market, by Product Sort, By way of 2029
Desk 84: Argentine Oncology Diagnostics Market, by Utility, By way of 2029
Desk 85: Argentine Oncology Diagnostics Market, by Finish Consumer, By way of 2029
Desk 86: Remainder of South American Oncology Diagnostics Market, by Product Sort, By way of 2029
Desk 87: Remainder of South American Oncology Diagnostics Market, by Utility, By way of 2029
Desk 88: Remainder of South American Oncology Diagnostics Market, by Finish Consumer, By way of 2029
Desk 89: Center East and African Oncology Diagnostics Market, by Product Sort, By way of 2029
Desk 90: Center East and African Oncology Diagnostics Market, by Utility, By way of 2029
Desk 91: Center East and African Oncology Diagnostics Market, by Finish Consumer, By way of 2029
Desk 92: Firm Shares within the Oncology Diagnostics Market, 2023
Desk 93: ESG: Environmental Overview
Desk 94: ESG: Social Overview
Desk 95: ESG: Governance Overview
Desk 96: Abbreviations Used on this Report
Desk 97: Abbott: Firm Snapshot
Desk 98: Abbott: Monetary Efficiency, FY 2022 and 2023
Desk 99: Abbott: Product Portfolio
Desk 100: Agilent Applied sciences Inc.: Firm Snapshot
Desk 101: Agilent Applied sciences Inc.: Monetary Efficiency, FY 2023 and 2024
Desk 102: Agilent Applied sciences Inc.: Product Portfolio
Desk 103: Agilent Applied sciences Inc.: Information/Key Developments, 2024
Desk 104: BD: Firm Snapshot
Desk 105: BD: Monetary Efficiency, FY 2023 and 2024
Desk 106: BD: Product Portfolio
Desk 107: bioMerieux: Firm Snapshot
Desk 108: bioMerieux: Monetary Efficiency, FY 2022 and 2023
Desk 109: bioMerieux: Product Portfolio
Desk 110: Bio-Rad Laboratories Inc.: Firm Snapshot
Desk 111: Bio-Rad Laboratories Inc.: Monetary Efficiency, FY 2023 and 2024
Desk 112: Bio-Rad Laboratories Inc.: Product Portfolio
Desk 113: Danaher Corp.: Firm Snapshot
Desk 114: Danaher Corp.: Monetary Efficiency, FY 2022 and 2023
Desk 115: Danaher Corp.: Product Portfolio
Desk 116: Danaher Corp.: Information/Key Developments, 2023
Desk 117: F. Hoffmann-La Roche Ltd.: Firm Snapshot
Desk 118: F. Hoffmann-La Roche Ltd.: Monetary Efficiency, FY 2023 and 2024
Desk 119: F. Hoffmann-La Roche Ltd.: Product Portfolio
Desk 120: F. Hoffmann-La Roche Ltd.: Information/Key Developments, 2024 and 2025
Desk 121: GE HealthCare: Firm Snapshot
Desk 122: GE HealthCare: Monetary Efficiency, FY 2023 and 2024
Desk 123: GE HealthCare: Product Portfolio
Desk 124: GE HealthCare: Information/Key Developments, 2024
Desk 125: Illumina Inc.: Firm Snapshot
Desk 126: Illumina Inc.: Monetary Efficiency, FY 2023 and 2024
Desk 127: Illumina Inc.: Product Portfolio
Desk 128: Illumina Inc.: Information/Key Developments, 2024
Desk 129: Koninklijke Philips N.V.: Firm Snapshot
Desk 130: Koninklijke Philips N.V.: Monetary Efficiency, FY 2023 and 2024
Desk 131: Koninklijke Philips N.V.: Product Portfolio
Desk 132: Merck KGaA: Firm Snapshot
Desk 133: Merck KGaA: Monetary Efficiency, FY 2022 and 2023
Desk 134: Merck KGaA: Product Portfolio
Desk 135: Myriad Genetics Inc.: Firm Snapshot
Desk 136: Myriad Genetics Inc.: Monetary Efficiency, FY 2022 and 2023
Desk 137: Myriad Genetics Inc.: Product Portfolio
Desk 138: Myriad Genetics Inc.: Information/Key Developments, 2025
Desk 139: Qiagen: Firm Snapshot
Desk 140: Qiagen: Monetary Efficiency, FY 2022 and 2023
Desk 141: Qiagen: Product Portfolio
Desk 142: Siemens Healthineers AG: Firm Snapshot
Desk 143: Siemens Healthineers AG: Monetary Efficiency, FY 2023 and 2024
Desk 144: Siemens Healthineers AG: Product Portfolio
Desk 145: Siemens Healthineers AG: Information/Key Developments, 2024
Desk 146: Thermo Fisher Scientific Inc.: Firm Snapshot
Desk 147: Thermo Fisher Scientific Inc.: Monetary Efficiency, FY 2022 and 2023
Desk 148: Thermo Fisher Scientific Inc.: Product Portfolio
Desk 149: Thermo Fisher Scientific Inc.: Information/Key Developments, 2023
Desk 150: ZytoVision GmbH: Firm Snapshot
Desk 151: ZytoVision GmbH: Product Portfolio
Desk 152: Rising Startups in Oncology Diagnostics Market
Record of Figures
Abstract Determine: World Market Shares of Oncology Diagnostics, by Product Sort, 2023
Determine 1: Porter’s 5 Forces Evaluation of the Oncology Market
Determine 2: Market Dynamics of Oncology Diagnostics
Determine 3: World Incidence Shares of All Most cancers Instances, by Area, 2022
Determine 4: Variety of FDA-Permitted Companion Diagnostic Units, 1997-2024
Determine 5: Rising Developments and Applied sciences in Oncology Diagnostics
Determine 6: Share of World Marketplace for Oncology Diagnostics, by Product Sort, 2023
Determine 7: Share of World Marketplace for Oncology Diagnostics, by Utility, 2023
Determine 8: Shares of World Marketplace for Oncology Diagnostics, by Finish Consumer, 2023
Determine 9: Share of World Marketplace for Oncology Diagnostics, by Area, 2023
Determine 10: Share of North American Marketplace for Oncology Diagnostics, by Nation, 2023
Determine 11: Share of European Marketplace for Oncology Diagnostics, by Nation, 2023
Determine 12: Breast Most cancers Screening Charges in Europe, by Nation, 2012 vs. 2022
Determine 13: Cervical Most cancers Screening Charges in European International locations, 2022
Determine 14: Colorectal Most cancers Screening Charges in European International locations, 2022
Determine 15: Present and Forecasted Most cancers Prevalence within the U.Okay., 2020-2040
Determine 16: Shares of Most cancers Instances in Asia and Oceania, Each Sexes, by Most cancers Sort, 2022
Determine 17: Shares of All Most cancers Mortality Instances in Asia and Oceania, Each Sexes, by Most cancers Sort, 2022
Determine 18: Share of Asia-Pacific Marketplace for Oncology Diagnostics, by Nation, 2023
Determine 19: Share of South American Marketplace for Oncology Diagnostics, by Nation, 2023
Determine 20: Share of the World Marketplace for Oncology Diagnostics, by Firm, 2023
Determine 21: ESG Pillars
Determine 22: Benefits of ESG for Corporations
Determine 23: Abbott: Income Share, by Enterprise Unit, FY 2023
Determine 24: Abbott: Income Share, by Nation/Area, FY 2023
Determine 25: Agilent Applied sciences Inc.: Income Share, by Enterprise Unit, FY 2024
Determine 26: Agilent Applied sciences Inc.: Income Share, by Nation/Area, FY 2024
Determine 27: BD: Income Share, by Enterprise Unit, FY 2024
Determine 28: BD: Income Share, by Nation/Area, FY 2024
Determine 29: bioMerieux: Income Share, by Enterprise Unit, FY 2023
Determine 30: bioMerieux: Income Share, by Area, FY 2023
Determine 31: Bio-Rad Laboratories Inc.: Income Share, by Enterprise Unit, FY 2024
Determine 32: Bio-Rad Laboratories Inc.: Income Share, by Nation/Area, FY 2024
Determine 33: Danaher Corp.: Income Share, by Enterprise Unit, FY 2023
Determine 34: Danaher Corp.: Income Share, by Nation/Area, FY 2023
Determine 35: F. Hoffmann-La Roche Ltd.: Income Share, by Enterprise Unit, FY 2024
Determine 36: F. Hoffmann-La Roche Ltd.: Income Share, by Enterprise Unit, FY 2024
Determine 37: GE HealthCare: Income Share, by Enterprise Unit, FY 2024
Determine 38: GE HealthCare: Income Share, by Nation/Area, FY 2024
Determine 39: Illumina Inc.: Income Share, by Enterprise Unit, FY 2024
Determine 40: Illumina Inc.: Income Share, by Nation/Area, FY 2024
Determine 41: Koninklijke Philips N.V.: Income Share, by Enterprise Unit, FY 2024
Determine 42: Koninklijke Philips N.V.: Income Share, by Nation/Area, FY 2023
Determine 43: Merck KGaA: Market Share, by Enterprise Unit, 2023
Determine 44: Merck KGaA: Income Share, by Nation/Area, 2023
Determine 45: Myriad Genetics Inc.: Income Share, by Enterprise Unit, 2023
Determine 46: Myriad Genetics Inc.: Income Share, by Nation/Area, 2023
Determine 47: Qiagen: Income Share, by Enterprise Unit, FY 2023
Determine 48: Qiagen: Income Share, by Nation/Area, FY 2023
Determine 49: Siemens Healthineers AG: Income Share, by Enterprise Unit, FY 2024
Determine 50: Siemens Healthineers AG: Income Share, by Nation/Area, FY 2024
Determine 51: Thermo Fisher Scientific Inc.: Income Share, by Enterprise Unit, 2023
Determine 52: Thermo Fisher Scientific Inc.: Income Share, by Nation/Area, 2023
Corporations Featured
- Abbott
- Agilent Applied sciences Inc.
- BD
- bioMerieux
- Bio-Rad Laboratories Inc.
- Danaher Corp.
- F. Hoffmann-La Roche Ltd.
- GE Healthcare
- Illumina Inc.
- Koninklijke Philips N.V.
- Merck KGaA
- Myriad Genetics Inc.
- QIAGEN
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
- ZytoVision GmbH
For extra details about this report go to https://www.researchandmarkets.com/r/80hrjw
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s main supply for worldwide market analysis experiences and market information. We offer you the newest information on worldwide and regional markets, key industries, the highest corporations, new merchandise and the newest developments.
